1.
Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis . Clinics [Internet]. 2014 Aug. 1 [cited 2024 May 17];69(8):547-53. Available from: https://www.revistas.usp.br/clinics/article/view/83973